Boehringer Ingelheim collaborates with CDR-Life to develop antibody fragment-based therapeutics for geographic atrophy

The geographic atrophy is a progressive, irreversible retinal disease that occurs in patients with age-related macular degeneration. (Credit: Alexas_Fotos from Pixabay)